<SEC-DOCUMENT>0001493152-24-015031-index.html : 20240417 <SEC-HEADER>0001493152-24-015031.hdr.sgml : 20240417 <ACCEPTANCE-DATETIME>20240417160732 ACCESSION NUMBER: 0001493152-24-015031 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 10 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invizyne Technologies Inc CENTRAL INDEX KEY: 0002010788 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834550057 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-276987 FILM NUMBER: 24851036 BUSINESS ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: (626) - 415 - 1488 MAIL ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>forms-1a.htm <TEXT> Document 1 - file: forms-1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ex1-1.htm <TEXT> Document 2 - file: ex1-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>ex4-2.htm <TEXT> Document 3 - file: ex4-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>4 <FILENAME>ex4-3.htm <TEXT> Document 4 - file: ex4-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>5 <FILENAME>ex10-4.htm <TEXT> Document 5 - file: ex10-4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.5 <SEQUENCE>6 <FILENAME>ex10-5.htm <TEXT> Document 6 - file: ex10-5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>7 <FILENAME>ex23-2.htm <TEXT> Document 7 - file: ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>8 <FILENAME>ex107-1.htm <TEXT> Document 8 - file: ex107-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex1-1_001.jpg <TEXT> Document 9 - file: ex1-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>forms-1a_001.jpg <TEXT> Document 10 - file: forms-1a_001.jpg
</DOCUMENT> </SEC-DOCUMENT>